The use of commercially available antibodies in this study guarantees the reproducibility of analyses across diverse cohorts, thereby advancing our comprehension of Tn and STn antigen expression in esophageal adenocarcinoma (EAC) and other tumor pathologies. Here, EEF1A2 is linked to esophageal adenocarcinoma.